Autopsy report · NCT01391715

Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD

“patients could not be recuited within study duration”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Inje University

Sponsor type

University, hospital or other

Conditions

Gastroesophageal Reflux Disease

Interventions

rabeprazole; standard dose rabeprazole

Participants

0

Sites

1

Countries

South Korea

Trials that died the same way

• Use of Hand Prosthesis With Direct Nerve Stimulation for Treatment of Phantom Limb Pain
  “Study has been completed in terms of duration but no patient has been recruited during this time” (74% match in meaning)
• Stop Exogenous Allergic Alveolitis (EAA) in Childhood
  “After several years of recruitment only 4 patients were included. Study timelines for study completition too long. Decided to terminate trial.” (70% match in meaning)
• Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
  “The study was terminated early due to the inability to recruit the planned number of patients” (69% match in meaning)
• A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
  “Study stopped early due to low patient accrual.” (69% match in meaning)
• The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
  “Study terminated due to lack of eligible patients” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.